FDA Import Refusal 799-9880376-1/41/2 — Janssen Inc.

Janssen Inc. — FEI 3002594622

The FDA refused shipment 799-9880376-1/41/2 from Janssen Inc. (Canada) on Mar 15, 2024. The refused product falls under Drugs and Biologics — CANAGLIFLOZIN (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.